Updating "Dataset of transcriptomic changes that occur in human preadipocytes over a 3-day course of exposure to 3,3',4,4',5-Pentachlorobiphenyl (PCB126)" with additional data on exposure to 2,2',5,5'-tetrachlorobiphenyl (PCB52) or its 4-hydroxy metabolite (4-OH-PCB52).
Adipose
Diabetes
Metabolite
Obesity
PCB52
Polychlorinated Biphenyls
Preadipocytes
RNAseq
Journal
Data in brief
ISSN: 2352-3409
Titre abrégé: Data Brief
Pays: Netherlands
ID NLM: 101654995
Informations de publication
Date de publication:
Aug 2023
Aug 2023
Historique:
received:
09
06
2023
revised:
10
07
2023
accepted:
11
07
2023
medline:
31
7
2023
pubmed:
31
7
2023
entrez:
31
7
2023
Statut:
epublish
Résumé
Polychlorinated biphenyls (PCBs) were used extensively in building materials, including those used in schools. PCBs accumulate in fat, and exposure to PCBs is associated with the development of cancer, neurodevelopmental disorders, cardiovascular disease, obesity, and diabetes. The non-dioxin-like PCB congener, PCB52 (2,2',5,5'-tetrachlorobiphenyl), is found at one of the highest levels of any congener in school air. PCB52 is oxidized in the liver to hydroxylated forms, mainly 4-OH-PCB52 (2,2',5,5'-tetrachlorobiphenyl-4-ol). In a previous study, we reported on RNAseq data generated from exposure of human preadipocytes to the dioxin-like PCB congener, PCB126. In this new dataset, we used identical techniques to examine alterations in gene transcript levels in human preadipocytes exposed to PCB52 or 4-OH-PCB52 over a time course. This updated set of data provides a comprehensive transcriptional profile of changes that occur in preadipocytes exposed to PCB52 or 4-OH-PCB52 over time and allows for comparison of these changes between the parent compound and its hydroxy metabolite. The datasets will allow others to explore how PCB52 and 4-OH-PCB52 impact biological pathways in preadipocytes. Further studies can be performed to determine how these changes might lead to disease.
Identifiants
pubmed: 37520642
doi: 10.1016/j.dib.2023.109415
pii: S2352-3409(23)00516-4
pmc: PMC10375549
doi:
Types de publication
Journal Article
Langues
eng
Pagination
109415Subventions
Organisme : NCI NIH HHS
ID : P30 CA086862
Pays : United States
Organisme : NIEHS NIH HHS
ID : P30 ES005605
Pays : United States
Organisme : NIEHS NIH HHS
ID : P42 ES013661
Pays : United States
Informations de copyright
© 2023 The Author(s).
Déclaration de conflit d'intérêts
The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Références
Toxicol In Vitro. 2015 Feb;29(1):132-41
pubmed: 25304490
PLoS One. 2013 Oct 30;8(10):e77988
pubmed: 24205055
Toxicol In Vitro. 2022 Sep;83:105396
pubmed: 35618242
Toxicol In Vitro. 2023 Jun;89:105568
pubmed: 36804509
Data Brief. 2022 Sep 01;45:108571
pubmed: 36131953
Environ Sci Technol. 2016 May 17;50(10):5320-7
pubmed: 27116425
Environ Sci Pollut Res Int. 2018 Jun;25(17):16508-16521
pubmed: 29322390
Toxicol Appl Pharmacol. 2003 Jan 1;186(1):55-62
pubmed: 12583993
Environ Sci Technol. 2023 Jan 31;57(4):1731-1742
pubmed: 36651682
Environ Sci Technol. 2019 Apr 2;53(7):3948-3958
pubmed: 30821444
Environ Sci Pollut Res Int. 2018 Jun;25(17):16481-16492
pubmed: 28699004